About

David Spaight has served as a Certara director since 2022 as an Arsenal Capital Partners designee and sits on the Compensation Committee. He has been an Operating Partner at Arsenal Capital Partners since 2016 and previously served as Chairman and CEO of contract research organization WIL Research from 2010 to 2016 and as President of MDS Pharma Services. He has held executive roles at Fisher Scientific and PerkinElmer, chaired the Association of Clinical Research Organizations, and holds a B.S. and an MBA from the University of Michigan.

Roles

Certara, Inc.
Director (Arsenal-designated) · Current role
2022–present
WIL Research
Chairman & CEO (2010-2016)
—
MDS Pharma Services
President
—
Fisher Scientific
Senior executive
—
PerkinElmer
Senior executive
—

External Roles

Arsenal Capital Partners
Operating Partner
—
CellCarta
Director
—

Also at Certara, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.